Loading...
Header Logo

Please contact dabioye@childrensnational.org for any questions. Can't find your name in profiles ? Request a Profile

Keywords
Last Name
Institution

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan.

Packer RJ, Jakacki R, Horn M, Rood B, Vezina G, MacDonald T, Fisher MJ, Cohen B. Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan. Pediatr Blood Cancer. 2009 Jul; 52(7):791-5.

View in: PubMed